HUFFPOST
If you want to understand why the Biden administration gets so little credit for its accomplishments ― and why, perhaps, it deserves to get a little more ― pay attention to a little-noticed policy announcement from last Friday.
The announcement was a list of 43 prescription drugs that are covered by Medicare and whose prices have risen faster than the rate of inflation. The list included relatively well-known drugs like Humira, which treats a variety of inflammatory conditions, plus some more obscure medications like Leukine, which helps cancer patients undergoing chemotherapy stave off infection.
Until recently, such price hikes would have simply meant higher costs for the Medicare program ― and for individual seniors paying out of pocket. Or, to put it more bluntly, American taxpayers as well as American consumers were at the complete mercy of the drug industry’s pricing.
But that’s…
